iCubate
Company Details
Status: Private
Employees: 11-50
Location:
Huntsville, Alabama, United States
Type:
sample
sample
Technology:
sample
About: Rapid Syndromic Testing for All Labs
The mission of iCubate® is to provide rapid, accurate and affordable syndromic testing to all laboratories to ensure care providers have the right tools to improve care and outcomes for their patients. The iCubate® team has developed the iC System™, a low-cost, fully automated, molecular diagnostic platform using armPCR technology, along with a suite of syndromic infectious diseases panels, including sepsis/positive blood cultures, upper / lower respiratory tract infections, GI, mycobacteria, and more.
Why iCubate for your lab?
• Rapid syndromic testing for infectious diseases for better care, sooner
• Affordable system increasing accessibility for large and small labs
• Multiplex assay with high target specificity and sensitivity for actionable results
• 3 minutes of hands-on time with routine lab processes
Twitter: @iCubate
FDA Cleared Products
iC-System™ (iCubate’s platform)
iC-GPC Assay™ for Gram positive cocci
Anticipated clearance 2019
iC-GN Assay™ for Gram negative rods
Robust Assay Pipeline
GI, Respiratory, Mycobacterium
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
iCubate | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.